To explore this hypothesis, we investigated the relationship between tumor-stroma interaction as quantified by our model and the expression of the stromal markers ACTA2 — using α-smooth muscle actin (αSMA), a marker for activated fibroblast — and PECAM1 — using CD31, a marker for angiogenesis (20). The gene discussed is ACTA2; the disease is neoplasm.